Results 91 to 100 of about 47,011 (239)

Characterising Hepatitis D Virus in the UK From 2011 to 2021

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 9, September 2026.
ABSTRACT Little is known about hepatitis B virus (HBV) and Hepatitis D virus (HDV) coinfection in the UK. HDV screening is recommended among all individuals with HBV, with coinfection associated with increased disease progression. Using data on HDV testing, shared by 11 laboratories in the UK who reported undertaking HDV testing, and national testing ...
R. Simmons   +67 more
wiley   +1 more source

Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.

open access: yesIntervirology, 2010
Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests.
Veropalumbo E.   +12 more
openaire   +5 more sources

Validation of a Point‐Of‐Care Ultrasound for Hepatitis Among Front‐Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 9, September 2026.
ABSTRACT To close gaps in implementing care of people with hepatitis B virus (HBV) infection in resource‐limited settings, we evaluated the accuracy of a novel liver point‐of‐care ultrasound (POCUS) protocol for hepatitis (PUSH) among front‐line non‐radiology healthcare workers in Zambia. At University Teaching Hospital in Lusaka, Zambia, from March to
Costanza Bertoni   +15 more
wiley   +1 more source

Prevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta‐Analysis

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 9, September 2026.
ABSTRACT Chronic hepatitis B virus (HBV) infection is a global public health problem, and many regions of Sub‐Saharan Africa are disproportionately affected, including Cameroon, where prevalence has previously been shown to be high. This study aimed to provide up‐to‐date estimates of HBV prevalence in Cameroon.
Iya Maliki   +4 more
wiley   +1 more source

Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population‐Based Spatial Analysis

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 9, September 2026.
ABSTRACT Chronic hepatitis B (CHB) and hepatitis D virus (HDV) coinfection are major causes of cirrhosis and hepatocellular carcinoma. The geographic distribution of CHB and alignment of anti‐HDV testing with CHB burden remain poorly defined. We aimed to examine if anti‐HDV testing and seropositivity align with areas of highest CHB burden.
Bryce Tkachuk   +5 more
wiley   +1 more source

Comparison of Rapid Diagnostic Test with Enzyme-Linked Immunosorbent Assay and PCR for Detection of Hepatitis B Surface Antigen

open access: yesAhi Evran Medical Journal
Purpose: Hepatitis B virus (HBV) infection is a global public health problem with significant morbidity and mortality rates and the detection of HBsAg is a very important test for diagnosis.
Melek Bilgin   +3 more
doaj   +1 more source

Barriers to Hepatitis B Treatment: A Multicentre Cross‐Sectional Registry and Survey Study by the Canadian Hepatitis B Network

open access: yesLiver International, Volume 46, Issue 9, September 2026.
ABSTRACT Background & Aims Chronic hepatitis B (CHB) remains a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, yet treatment uptake is suboptimal even in high‐resource settings. This pan‐Canadian study aimed to quantify treatment gaps within the Canadian Hepatitis B Network (CanHepB) Registry, compare characteristics of ...
Hin Hin Ko   +32 more
wiley   +1 more source

CORRELATION BETWEEN SGOT AND SGPT LEVELS WITH POSITIVE HBsAg LEVELS

open access: yesJournal of Vocational Health Studies
Background: Serum Glutamic Oxaloacetate Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) are transaminase enzymes used to determine liver damage. The increase in both enzymes can indicate the level of liver cell damage.
Nisa'ur Rosyidah   +4 more
doaj   +1 more source

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations

open access: yesACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Background Intravenous Ig (IVIG) is used in the management of a wide array of medical conditions. Passive transfer of hepatitis B core antibody (anti‐HBc) following IVIG administration is a well‐recognized, but often underappreciated phenomenon that can complicate the interpretation of hepatitis B serologies.
Mark McPherson   +2 more
wiley   +1 more source

Secondary Hemophagocytic Lymphohistiocytosis Complicated by Mucormycosis Following Liver Transplantation for Cryptogenic Acute Liver Failure: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT HLH must be suspected in liver transplant patients who exhibit fever, cytopenia, hyperferritinemia, and dysfunction of the graft. HLH‐2004 guidelines and H‐score assessment early on will aid in early diagnosis and management, although prognosis remains poor when there are opportunistic infections.
Saif Ali Malik   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy